Skip to content
Vensana

Vensana

  • Our Team
  • Values
  • Our Entrepreneurs

Category: Portfolio News

Portfolio News

Curate Biosciences launches its first product to transform cell therapy manufacturing costs and performance

Portfolio News

Volta Medical Secures €36M in Series B Funding to Support Adoption of its AI Software for Cardiac Ablation

Portfolio News

Curate Biosciences Announces David Backer as Chief Executive Officer

Portfolio News

Nyra Medical Announces $20 Million Series A Financing for its Transcatheter Heart Valve Repair Technology

Portfolio News

Heart Health Innovator Cleerly Closes Series C Funding Round with $223 Million

Portfolio News

Moxe Health Raises $30M Series B to Further Advance Interoperability

Portfolio News

Labcorp Strengthens Oncology Leadership Position With the Addition of Personal Genome Diagnostics

Portfolio News

Apella Announces $21 Million Series A Funding to Digitize the Operating Room

Portfolio News

Philips to further expand its image-guided therapy devices portfolio through acquisition of Vesper Medical

Portfolio News

CVRx, Inc. Announces Upsized Pricing of Initial Public Offering

Portfolio News

This AI Startup Raised $43 Million To Save Lives (And Money) By Treating Heart Disease Earlier

Portfolio News

Cleerly Launches with $43 Million Series B to Provide a New Standard of Care for the Leading Cause of Death – Heart Disease

Portfolio News

GPB Scientific Announces Additional Growth Financing to Support Commercialization of Curate™ Cell Processing System for Next-Generation Cell & Gene Therapies

Portfolio News

Personal Genome Diagnostics Announces Close of $103 Million Series C Financing

Portfolio News

SpyGlass Ophthalmics Completes $27.5 Million Series B Financing to Advance Novel Treatments for Chronic Ophthalmic Diseases

Portfolio News

Relievant Medsystems Announces $70M Financing to Accelerate U.S. Commercialization of Intracept Procedure

Portfolio News

Philips to expand its image-guided therapy devices portfolio through acquisition of Intact Vascular

Portfolio News

CVRx® Raises $50 Million in New Equity Financing

Portfolio News

GPB Scientific Announces $25.5 Million Financing from Vensana Capital and Amgen Ventures

Portfolio News

Two medical device makers in Wayne get big boosts

Portfolio News

Wayne medical device developer and its spin-off reel in $62 million

Portfolio News

Vesper Medical Announces $37 Million Financing with Vensana Capital and Gilde Healthcare to Complete Development of Its Duo Venous Stent System™

Portfolio News

Intact Vascular Announces $25 Million Financing with Vensana Capital to Drive Commercialization of the Tack Endovascular System®

Portfolio News

Intact Vascular, Vesper Medical Raise Capital to Tackle Blood-Vessel Diseases

21

Novel FDA PMA & de novo 510k approvals

60

U.S. Commercial Product Launches

40

Level I Clinical Trials

32

Strategic Financings

31

Exits by IPO or M&A

VENSANA CAPITAL

CAPITAL PARTNERS FOR HEALTHCARE ENTREPRENEURS®

Ready to change healthcare together? Contact us to arrange for investments in development and commercial stage companies.

Get in Touch

Our Latest

See All News
MedTech Strategist: Vensana Capital Closes Its Third Medtech Fund for $425 Million
Rampart IC Secures Series B Financing to Fuel Strategic Growth and Expand Access to Radiation Safety Solutions
Medtech Talk Podcast: Host Justin Klein with Douglas Kelly on the Value of Innovation and Breakthrough Designation
Resources
News LP Access
Contact
[email protected] 612.217.8680
Engage
Minneapolis
Vensana Capital 3601 W 76th Street Suite 20 Minneapolis, MN 55435
Washington, D.C.
Vensana Capital 101 Church Street Suite D Vienna, VA 22180

© 2025 Vensana Capital Management, LLC | Privacy | Terms & Conditions